Letter to the EditorColorectal cancer risk associated with the CHEK2 1100delC variant
Section snippets
Conflict of interest statement
None declared.
References (9)
- et al.
Meta-analysis of CHEK2 1100delC variant and colorectal cancer susceptibility
Eur J Cancer
(2011) - et al.
The CHEK2 gene I157T mutation and other alterations in its proximity increase the risk of sporadic colorectal cancer in the Czech population
Eur J Cancer
(2009) - et al.
Genetic variants associated with colorectal cancer risk: comprehensive research synopsis, meta-analysis, and epidemiological evidence
Gut
(2014) - National Comprehensive Cancer Network. Genetic/familial high-risk assessment: colorectal (Version...
There are more references available in the full text version of this article.
Cited by (10)
Use of Family History and Genetic Testing to Determine Risk of Colorectal Cancer
2020, GastroenterologyCitation Excerpt :Highly penetrant cancer syndromes that increase risk of CRC include hereditary breast and ovarian cancer (associated with pathogenic variants in BRCA1, BRCA2, and PALB2 genes), Li-Fraumeni syndrome (caused by mutations in TP53), and familial atypical multiple melanoma (associated with pathogenic variants in CDKN2A).17,19,69–72 Cancer syndromes of moderate penetrance that are associated with breast cancer and increase risk of CRC are caused by variants in the ATM and CHEK2 genes.73–75 Studies are under way to quantify the risk of CRC related to these variants, and surveillance recommendations for CRC prevention are often modified.
Germline Variants and Characteristic Features of Hereditary Hematological Malignancy Syndrome
2024, International Journal of Molecular SciencesGenetic Predisposition to Colorectal Cancer: How Many and Which Genes to Test?
2023, International Journal of Molecular SciencesGermline CHEK2 and ATM Variants in Myeloid and Other Hematopoietic Malignancies
2022, Current Hematologic Malignancy Reports
© 2017 Elsevier Ltd. All rights reserved.